Analysis of a human immunodeficiency virus type 1 Gag mutant with an engineered 110-amino-acid insertion in the matrix protein domain

Journal of Medical Virology

Volumn 61, Issue 4, 2000, Pages 423-432

  Wang, Chin Tien ^a   Yang, An Hang ^a   Chiang, Chien Cheng ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Gag; Human immunodeficiency virus; Matrix protein; Virus assembly

Indexed keywords

AMINO ACID; GAG PROTEIN; MATRIX PROTEIN; MUTANT PROTEIN; RNA DIRECTED DNA POLYMERASE; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME ASSAY; GENE INSERTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; PROTEIN ANALYSIS; PROTEIN DOMAIN; RNA ANALYSIS; VIRUS ASSEMBLY; VIRUS INFECTIVITY; VIRUS PARTICLE;

BLOTTING, WESTERN; CELL LINE; CODON; DNA TRANSPOSABLE ELEMENTS; GENES, GAG; HELA CELLS; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; MUTATION; RNA, VIRAL; RNA-DIRECTED DNA POLYMERASE; TRANSFECTION; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY;

EID: 0033949138     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(200008)61:4<423::AID-JMV3>3.0.CO;2-9     Document Type: Article

References (53)

1. Borsetti A, Ohagen A, Gottlinger HG. 1998. The C-terminal half of the human immunodeficiency virus type 1 gag precursor is sufficient for efficient particle assembly. J Virol 72:9313-9317.
2. Bryant M, Ratner L. 1990. Myristylation-dependent replication and assembly of human immunodeficiency virus 1. Proc Natl Acad Sci USA 87:523-527.
3. Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M. 1993a. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cell. Nature 365:666-669.
4. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M. 1993b. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acid following acute infection. Proc Natl Acad Sci USA 90:6125-6129.
5. Cannon PM, Matthews S, Clark N, Byles ED, Iourin O, Hockley DJ, Kingsman SM, Kingsman AJ. 1997. Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J Virol 71:3474-3483.
6. Chen, YL, Ts'ai, PW, Yang CC, Wang CT. 1997. Generation of infectious virus particles by transient co-expression of human immunodeficiency virus type 1 gag mutants. J Gen Virol 78:2497-2501.
7. Dorfman T, Mammano F, Haseltine WA, Gottlinger HG. 1994. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol 68:1689-1696.
8. Facke M, Janetzko A, Shoeman R, Krausslich HG. 1993. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J Virol 67:4972-4980.
9. Fouchier RAM, Meyer BE, Simon JHM, Fischer U, Malim MH. 1997. HIV-1 infection of non-dividing cells: evidence that the aminoterminal basic region of the viral matrix protein is important for gag processing but not for post-entry nuclear import. EMBO J 16:4531-4539.
10. Freed EO, Martin MA. 1995. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific single amino acid substitution in the human immunodeficiency virus type 1 matrix. J Virol 69:1984-1989.
11. Freed EO, Orenstein JM, Buckler-White AJ, Martin MA. 1994. Single amino acid changes in the human immunodeficiency virus type 1matrix protein block virus particle production. J Virol 68:5311-5320.
12. Freed EO, Englund G, Marti, MA. 1995. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol 69:3949-3954.
13. Freed EO, Englund G, Maldarelli F, Martin MA. 1997. Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell 88:171-174.
14. Gallay P, Swingler S, Aitken C, Trono D. 1995. HIV-1 infection of non-dividing cells: C-terminal phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-388.
15. Gelderblom HR. 1991. Assembly and morphology of HIV: potential effect of structure on viral function. AIDS 5:617-638.
16. Gelderblom HR, Hausmann E HS, Ozel M, Pauli G, Koch MA. 1987. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural protein. Virology 156:171-176.
17. Gottlinger HG, Sodroski JG, Haseltine WA. 1989. Role of capsid precursor processing and myristylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 86:5781-5785.
18. Graham R, van der Eb A. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
19. Henderson LE, Bowers MA, Sowder II RC, Serabyn SA, Johnson DG, Bess JW Jr, Arthur LO, Bryant DK, Fenselau C. 1992. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processing, and complete amino acid sequences. J Virol 66:1856-1865.
20. Hill CP, Worthylake D, Bancroft DP, Christensen AM, Sundquist WI. 1996. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implication for membrane association and assembly. Proc Natl Acad Sci USA 93:3099-3104.
21. gag-pol into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein. J Virol 71:4472-4478.
22. Hunter E. 1994. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin Virol 5:71-83.
23. Kaplan AH, Manchester M, Swanstorm R. 1994. The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J Virol 68:6782-6786.
24. Kiernan RE, Ono A, Englund G, Freed EO. 1998. Role of matrix in an early post-entry step in the human immunodeficiency virus type 1 life cycle. J Virol 72:4116-4126.
25. Kohl NE, Emini EA, Schleif WE, Davis EJ, Heimbach JC, Dixon RAF, Scolnick EM, Sigal IS. 1988. Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci USA 85:4686-4690.
26. Leis J, Baltimore DJ, Bisthop B, Coffin J, Fleissner E, Goff SP, Oroszlan S, Robinson H, Skalka AM, Temin HM, Vogt V. 1988. Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol 62:1808-1809.
27. Mervis RJ, Ahmad N, Lillehoj EP, Raum MG, Salazar FHR, Chan HW, Venkatesan S. 1988. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modification, and evidence for alternative gag precursors. J Virol 62:3993-4002.
28. Morikawa V, Zhang WH, Hockley DJ, Nermut MV, Jones IM. 1998. Detection of a trimeric human immunodeficiency virus type Gag intermediate is dependent on sequences in the matrix protein, p17. J Virol 72:7659-7663.
29. Ono A, Huang M, Freed EO. 1997. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions. J Virol 71:4409-4418.
30. Page KA, Landau NR, Littman DR. 1990. Construction and use of a human immunodeficiency virus: vector for analysis of virus infectivity. J Virol 64:5270-5276.
31. Pal R, Reitz Jr MS, Tschanchler E, Gallo RC, Sarngadharan MG, Veronese FDM. 1990. Myristylation of gag proteins of HIV-1 plays an important role in virus assembly. AIDS Res Hum Retroviruses 6:721-730.
32. gag and is incorporated into viruslike particles. J Virol 66: 6304-6313.
33. Peng C, Ho BK, Chang TW, Chang NT. 1989. Role of human immunodeficiency virus type 1-specific protease in core particle maturation and viral infectivity. J Virol 63:2550-2556.
34. Pierce JC, Masker W. 1989. Genetic deletions between directly repeated sequences in bacteriophage T7. Mol Gen Genet 217:215-222.
35. Poon DTK, Li G, Aldovini A. 1998. Nucleocapsid and matrix protein contributes to selective human immunodeficiency virus type 1 genomic RNA packaging. J Virol 72:1983-1993.
36. Ratner L, Haseltine W, Patarea R, Livak KJ, Starcich B, Josephs SF, Doran ER, Rlfalski JA, Whitehorn EA, Baumeister K, Ivanoff L, Petteway SR Jr, Pearson ML, Lautenberger JA, Papas TS. Ghrayeb J, Chang NT, Gallo RC, Wong-Staal F. 1985. Complete nucleotide sequences of the AIDS virus, HTLV-III. Nature (London) 313:277-284.
37. Reicin AS, Paik S, Berkowitz RD, Luban J, Lowy I, Goff SP. 1995. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J Virol 69:642-650.
38. Reil H, Bukovsky AA, Gelderblom HR, Gottlinger HG. 1998. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J 17:2699-2708.
39. Schumacher S, Fuchs RP, Bichara M. 1997. Two distinct models account for short and long deletions within sequences repeats in Escherichia coli. J Bacteriol 179:6512-6517.
40. gag-pol from human immunodeficiency virus type 1 into virus-like particles. J Virol 67:2266-2275.
41. Spearman P, Wang JJ, Heyden NV, Ratner L. 1994. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J Virol 68: 3232-3242.
42. Srinivasakumar N, Hammarskjold ML, Rekosh D. 1995. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J Virol 69:6106-6114.
43. Wang CT, Barklis E. 1993. Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J Virol 67: 4264-4273.
44. Wang CT, Lai HY, Li JJ. 1998. Analysis of minimal human immunodeficiency virus type 1 (HIV-1) gag coding sequences capable of virus-like particle assembly and release. J Virol 72:7950-7959.
45. Wang CT, Li JJ, Lai HY, Hu BS. 1999. A human cell line constitutively expressing HIV-1 gag and Gag-Pol gene products. J Med Virol 57:17-24.
46. Wang CT, Zhang Y, McDermott J, Barklis E. 1993. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J Virol 67:7067-7076.
47. Weldon RA, Wills JW. 1993. Characterization of a small (25-kDa) derivative of the Rous sarcoma virus Gag protein competent for particle release. J Virol 67:5550-5561.
48. Wills JW, Craven RC. 1991. Form, function, and use of retroviral gag proteins. AIDS 5:639-654.
49. Yu X, Yu QC, Lee TH, Essex M. 1992a. The C-terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J Virol 66:5667-5670.
50. Yu X, Yuan X, Matsuda Z, Lee TH, Essex M. 1992b. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol 66:4966-4971.
51. Yuan X, Yu X, Lee TH, Essex M. 1993. Mutations in the N-terminal region of human immunodeficiency virus type 1matrix protein block intracellular transport of the Gag precursor. J Virol 67: 6387-6394.
52. Zhou W, Parent LJ, Wills JW, Resh MD. 1994. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein that interacts with acidic phospholipids. J Virol 68: 2556-2569.
53. Zhou W, Resh MD. 1996. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J Virol 70: 8640-8648.